keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RA-839 is a potent small molecule Keap1 conjugate and selective Nrf2 signalling activator, as well as an inhibitor of Keap1/Nrf2 interaction with anticancer activity.RA-839 inhibits the expression of inducible nitric oxide synthase and inhibits nitric oxide release.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 30,500 | |||
10 mg | 在庫あり | ¥ 45,000 | |||
25 mg | 在庫あり | ¥ 74,500 | |||
50 mg | 在庫あり | ¥ 111,000 |
説明 | RA-839 is a potent small molecule Keap1 conjugate and selective Nrf2 signalling activator, as well as an inhibitor of Keap1/Nrf2 interaction with anticancer activity.RA-839 inhibits the expression of inducible nitric oxide synthase and inhibits nitric oxide release. |
別名 | RA 839, RA839 |
分子量 | 452.57 |
分子式 | C25H28N2O4S |
CAS No. | 1832713-02-6 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (176.77 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RA-839 1832713-02-6 Immunology/Inflammation Nrf2 RA 839 RA839 Inhibitor inhibitor inhibit